|
1
|
Luo J, Zhou J, Cheng Q, Zhou C and Ding Z:
Role of microRNA-133a in epithelial ovarian cancer pathogenesis and
progression. Oncol Lett. 7:1043–1048. 2014.PubMed/NCBI
|
|
2
|
Tang AQ, Cao XC, Tian L, He L and Liu F:
Apigenin inhibits the self-renewal capacity of human ovarian cancer
SKOV3-derived sphere-forming cells. Mol Med Rep. 11:2221–2226.
2015.
|
|
3
|
Hays JL, Kim G, Walker A, Annunziata CM,
Lee JM, Squires J, Houston N, Steinberg SM and Kohn EC: A phase II
clinical trial of polyethylene glycol-conjugated L-asparaginase in
patients with advanced ovarian cancer: Early closure for safety.
Mol Clin Oncol. 1:565–569. 2013.
|
|
4
|
Chen WC, Lin MS, Ye YL, Gao HJ, Song ZY
and Shen XY: microRNA expression pattern and its alteration
following celecoxib intervention in human colorectal cancer. Exp
Ther Med. 3:1039–1048. 2012.PubMed/NCBI
|
|
5
|
Jiang JX, Zhang N, Liu ZM and Wang YY:
Detection of microRNA-21 expression as a potential screening
biomarker for colorectal cancer: A meta-analysis. Asian Pac J
Cancer Prev. 15:7583–7588. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan JK, Blansit K, Kiet T, Sherman A,
Wong G, Earle C and Bourguignon LY: The inhibition of miR-21
promotes apoptosis and chemosensitivity in ovarian cancer. Gynecol
Oncol. 132:739–744. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu S, Fang Y, Shen H, Xu W and Li H:
Berberine sensitizes ovarian cancer cells to cisplatin through
miR-21/PDCD4 axis. Acta Biochim Biophys Sin. 45:756–762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang L, Kuang LG, Zheng HC, Li JY, Wu DY,
Zhang SM and Xin Y: PTEN encoding product: A marker for
tumorigenesis and progression of gastric carcinoma. World J
Gastroenterol. 9:35–39. 2003.PubMed/NCBI
|
|
9
|
Wu H, Wang K, Liu W and Hao Q: PTEN
overexpression improves cisplatin-resistance of human ovarian
cancer cells through upregulating KRT10 expression. Biochem Biophys
Res Commun. 444:141–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lau MT, Klausen C and Leung PC: E-cadherin
inhibits tumor cell growth by suppressing PI3K/Akt signaling via
β-catenin-Egr1-mediated PTEN expression. Oncogene. 30:2753–2766.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lou Y, Yang X, Wang F, Cui Z and Huang Y:
MicroRNA-21 promotes the cell proliferation, invasion and migration
abilities in ovarian epithelial carcinomas through inhibiting the
expression of PTEN protein. Int J Mol Med. 26:819–827. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou X, Huang S, Jiang L, Zhang S, Li W,
Chen Z and Zhang D: Expression of RECK and MMP-2 in salivary
adenoid cystic carcinoma: Correlation with tumor progression and
patient prognosis. Oncol Lett. 7:1549–1555. 2014.PubMed/NCBI
|
|
13
|
Xue G, Zou X, Zhou JY, Sun W, Wu J, Xu JL
and Wang RP: Raddeanin A induces human gastric cancer cells
apoptosis and inhibits their invasion in vitro. Biochem Biophys Res
Commun. 439:196–202. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Masui T, Doi R, Koshiba T, Fujimoto K,
Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, et al:
RECK expression in pancreatic cancer: Its correlation with lower
invasiveness and better prognosis. Clin Cancer Res. 9:1779–1784.
2003.PubMed/NCBI
|
|
15
|
Zhang Y, Cheng S, Zhang G, Ma W, Liu Y,
Zhao R, Zhang Q and Pang D: Low expression of RECK indicates a
shorter survival for patients with invasive breast cancer. Cancer
Sci. 103:1084–1089. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qi Q, Lu N, Li C, Zhao J, Liu W, You Q and
Guo Q: Involvement of RECK in gambogic acid induced anti-invasive
effect in A549 human lung carcinoma cells. Mol Carcinog. Feb
14–2014.Epub ahead of print. View
Article : Google Scholar
|
|
17
|
Fejzo MS, Ginther C, Dering J, Anderson L,
Venkatesan N, Konecny G, Karlan B and Slamon DJ: Knockdown of
ovarian cancer amplification target ADRM1 leads to downregulation
of GIPC1 and upregulation of RECK. Genes Chromosomes Cancer.
50:434–441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahn MY, Kang DO, Na YJ, Yoon S, Choi WS,
Kang KW, Chung HY, Jung JH, Min do S and Kim HS: Histone
deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell
migration via class II histone deacetylase 4 silencing. Cancer
Lett. 325:189–199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sadahira K, Sagawa M, Nakazato T, Uchida
H, Ikeda Y, Okamoto S, Nakajima H and Kizaki M: Gossypol induces
apoptosis in multiple myeloma cells by inhibition of interleukin-6
signaling and Bcl-2/Mcl-1 pathway. Int J Oncol. 45:2278–2286.
2014.PubMed/NCBI
|
|
20
|
Xie YL, Yang YJ, Tang C, Sheng HJ, Jiang
Y, Han K and Ding LJ: Estrogen combined with progesterone decreases
cell proliferation and inhibits the expression of Bcl-2 via
microRNA let-7a and miR-34b in ovarian cancer cells. Clin Transl
Oncol. 16:898–905. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma C, Yin G, You F, Wei Y, Huang Z, Chen X
and Yan D: A specific cell-penetrating peptide induces apoptosis in
SKOV3 cells by down-regulation of Bcl-2. Biotechnol Lett.
35:1791–1797. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang L, Wang Y, Guo H and Guo M:
Synergistic anti-cancer effects of icariin and temozolomide in
glioblastoma. Cell Biochem Biophys. Nov 11–2014.Epub ahead of
print.
|
|
23
|
Zhou J, Wu J, Chen X, Fortenbery N,
Eksioglu E, Kodumudi KN, Pk EB, Dong J, Djeu JY and Wei S: Icariin
and its derivative, ICT, exert anti-inflammatory, anti-tumor
effects, and modulate myeloid derived suppressive cells (MDSCs)
functions. Int Immunopharmacol. 11:890–898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Q, Hao J, Pu J, Zhao L, Lü Z, Hu J,
Yu Q, Wang Y, Xie Y and Li G: Icariin induces apoptosis in mouse
MLTC-10 Leydig tumor cells through activation of the mitochondrial
pathway and down-regulation of the expression of piwil4. Int J
Oncol. 39:973–980. 2011.PubMed/NCBI
|
|
25
|
Nakamura K, Banno K, Yanokura M, Iida M,
Adachi M, Masuda K, Ueki A, Kobayashi Y, Nomura H, Hirasawa A, et
al: Features of ovarian cancer in Lynch syndrome (Review). Mol Clin
Oncol. 2:909–916. 2014.PubMed/NCBI
|
|
26
|
Li S, Li Y, Wen Z, Kong F, Guan X and Liu
W: microRNA-206 overexpression inhibits cellular proliferation and
invasion of estrogen receptor α-positive ovarian cancer cells. Mol
Med Rep. 9:1703–1708. 2014.PubMed/NCBI
|
|
27
|
Li S, Dong P, Wang J, Zhang J, Gu J, Wu X,
Wu W, Fei X, Zhang Z, Wang Y, et al: Icariin, a natural flavonol
glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via
a ROS/JNK-dependent mitochondrial pathway. Cancer Lett.
298:222–230. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang DC, Liu JL, Ding YB, Xia JG and Chen
GY: Icariin potentiates the antitumor activity of gemcitabine in
gallbladder cancer by suppressing NF-κB. Acta Pharmacol Sin.
34:301–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang B and Zhang Q: The expression and
clinical significance of circulating microRNA-21 in serum of five
solid tumors. J Cancer Res Clin Oncol. 138:1659–1666. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu M, Tang Q, Qiu M, Lang N, Li M, Zheng
Y and Bi F: miR-21 targets the tumor suppressor RhoB and regulates
proliferation, invasion and apoptosis in colorectal cancer cells.
FEBS Lett. 585:2998–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang C, Shi YR, Liu XR, Cao YC, Tian JL,
Jia ZY, Zhen D, Liu FH and Gao JM: The regulatory role of icariin
on apoptosis in mouse preimplantation embryos with reduced
microRNA-21. Theriogenology. 82:461–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Waite KA and Eng C: Protean PTEN: Form and
function. Am J Hum Genet. 70:829–844. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gu J, Tamura M and Yamada KM: Tumor
suppressor PTEN inhibits integrin- and growth factor-mediated
mitogen-activated protein (MAP) kinase signaling pathways. J Cell
Biol. 143:1375–1383. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Alexius-Lindgren M, Andersson E, Lindstedt
I and Engström W: The RECK gene and biological malignancy - its
significance in angiogenesis and inhibition of matrix
metalloproteinases. Anticancer Res. 34:3867–3873. 2014.PubMed/NCBI
|
|
35
|
Prosdócimi FC, Rodini CO, Sogayar MC,
Sousa SC, Xavier FC and Paiva KB: Calcifying cystic odontogenic
tumour: Immunohistochemical expression of matrix
metalloproteinases, their inhibitors (TIMPs and RECK) and inducer
(EMMPRIN). J Oral Pathol Med. 43:545–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu N, Zheng Y, Zhu Y, Xiong S and Chu Y:
Selective impairment of
CD4+CD25+Foxp3+ regulatory T cells
by paclitaxel is explained by Bcl-2/Bax mediated apoptosis. Int
Immunopharmacol. 11:212–219. 2011. View Article : Google Scholar
|
|
37
|
Li J, Sun GZ, Lin HS, Pei YX, Qi X, An C,
Yu J and Hua BJ: The herb medicine formula ‘Yang Wei Kang Liu’
improves the survival of late stage gastric cancer patients and
induces the apoptosis of human gastric cancer cell line through
Fas/Fas ligand and Bax/Bcl-2 pathways. Int Immunopharmacol.
8:1196–1206. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yao Y, Huang C, Li ZF, Wang AY, Liu LY,
Zhao XG, Luo Y, Ni L, Zhang WG and Song TS: Exogenous
phosphatidylethanolamine induces apoptosis of human hepatoma HepG2
cells via the bcl-2/Bax pathway. World J Gastroenterol.
15:1751–1758. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S and
Navab R: MicroRNA-21 (miR-21) regulates cellular proliferation,
invasion, migration, and apoptosis by targeting PTEN, RECK and
Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One.
9:e1036982014. View Article : Google Scholar : PubMed/NCBI
|
